Profile
Gary Ng Wang Yu is listed as a director of Niagen Bioscience, Inc. in the company’s SEC filings as of June 26, 2026. The available SEC context identifies him as serving on the board, but does not provide additional public biographical details beyond the director role. Name variations may appear in filings (e.g., Gary Ng Wang Yu, Ng Wang Yu Gary). The provided context does not indicate that he is deceased as of the filing date.
| Role | Director |
|---|
| Notability | 20/100 |
|---|
Board memberships
Awards & honors
- Director, Niagen Bioscience, Inc. (as of 2026-06-26)
Frequently Asked Questions
Who is Ng Wang Yu Gary?
Gary Ng Wang Yu is listed as a director of Niagen Bioscience, Inc. in the company’s SEC filings as of June 26, 2026. The available SEC context identifies him as serving on the board, but does not provide additional public biographical details beyond the director role. Name variations may appear in filings (e.g., Gary Ng Wang Yu, Ng Wang Yu Gary). The provided context does not i…
How many SEC Form 4 filings has Ng Wang Yu Gary submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Ng Wang Yu Gary's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.